Dr. Venniyil Radhakrishna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-5111Fax+1 414-805-2934
Education & Training
OtherClass of 2002
Certifications & Licensure
WI State Medical License 2021 - 2025
UT State Medical License 2013 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsAutologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy ...Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel
Bone Marrow Transplantation. 2024-05-01 - 4 citationsAdverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin
Blood Cancer Journal. 2024-03-05 - 3 citationsChimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.Lindsay Hammons, Shabi Haider, Andrew J Portuguese, Rahul Banerjee, Aniko Szabo
British Journal of Haematology. 2024-03-01
Press Mentions
New CAR T-cell Therapy Eliminates MM and Tumor Propagating Cells Without Fratricide in Lab StudyFebruary 26th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
